Cytometry Part B - Clinical Cytometry : Impact Factor & More
eISSN: 1552-4957pISSN: 1552-4949
Share this on:
Key Metrics
CiteScore 
6
Impact Factor
< 5
SNIP
1.2
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Cytometry Part B - Clinical Cytometry Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cytometry Part B - Clinical Cytometry ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cytometry Part B - Clinical Cytometry
Subtype-specific immunophenotypic and cytogenetic patterns complement flow-cytometric detection of measurable residual disease in B-lymphoblastic leukemia.
- 8 Aug 2026
- Cytometry. Part B, Clinical cytometry
Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort.
- 7 Aug 2026
- Cytometry. Part B, Clinical cytometry
Cytoplasmic staining of T cell receptor components enables efficient assessment of lineage and clonality in surface CD3-negative T cell neoplasms.
- 6 Aug 2026
- Cytometry. Part B, Clinical cytometry
Platelet flow cytometry: An evolving platform for clinical hematology.
- 5 Aug 2026
- Cytometry. Part B, Clinical cytometry
Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B-cell acute lymphoblastic leukemia: A report from The Cytometry Society, India.
- 4 Aug 2026
- Cytometry. Part B, Clinical cytometry
CD72 as a complementary B-lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR-T therapy in R/R B-ALL.
- 3 Aug 2026
- Cytometry. Part B, Clinical cytometry
Subtype-specific immunophenotypic and cytogenetic patterns complement flow-cytometric detection of measurable residual disease in B-lymphoblastic leukemia.
- 8 Aug 2026
- Cytometry. Part B, Clinical cytometry
Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort.
- 7 Aug 2026
- Cytometry. Part B, Clinical cytometry
Cytoplasmic staining of T cell receptor components enables efficient assessment of lineage and clonality in surface CD3-negative T cell neoplasms.
- 6 Aug 2026
- Cytometry. Part B, Clinical cytometry
Platelet flow cytometry: An evolving platform for clinical hematology.
- 5 Aug 2026
- Cytometry. Part B, Clinical cytometry
Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B-cell acute lymphoblastic leukemia: A report from The Cytometry Society, India.
- 4 Aug 2026
- Cytometry. Part B, Clinical cytometry
CD72 as a complementary B-lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR-T therapy in R/R B-ALL.
- 3 Aug 2026
- Cytometry. Part B, Clinical cytometry
FAQs on Cytometry Part B - Clinical Cytometry
How long has Cytometry Part B - Clinical Cytometry been actively publishing? 
What is the publishing frequency of Cytometry Part B - Clinical Cytometry?
How many articles did Cytometry Part B - Clinical Cytometry publish last year?
What is the eISSN & pISSN for Cytometry Part B - Clinical Cytometry?
What is Citescore for Cytometry Part B - Clinical Cytometry?
What is SNIP score for Cytometry Part B - Clinical Cytometry?
Who is the publisher of Cytometry Part B - Clinical Cytometry?
